| 000 | 01680 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513092159.0 | ||
| 264 | 0 | _c19960815 | |
| 008 | 199608s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800050499 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCascinu, S | |
| 245 | 0 | 0 |
_aMultimodal biochemical modulation of 5-fluorouracil by leucovorin, methotrexate, and interferon alpha in patients with advanced colorectal cancer. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1996 |
||
| 300 |
_a385-6 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aColorectal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFeasibility Studies |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadministration & dosage |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aRemission Induction |
| 700 | 1 | _aAlessandroni, P | |
| 700 | 1 | _aRossi, D | |
| 700 | 1 | _aDel Ferro, E | |
| 700 | 1 | _aFedeli, A | |
| 700 | 1 | _aCasadei, V | |
| 700 | 1 | _aCatalano, G | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 38 _gno. 4 _gp. 385-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800050499 _zAvailable from publisher's website |
| 999 |
_c8672009 _d8672009 |
||